Adolescent 1 Adult 1 Angiogenesis Inhibitors 1 Antibodies, Monoclonal, Humanized 1 Article 1 Cost-Benefit Analysis 1 Cross-Sectional Studies 1 Female 1 Humans 1 Male 1 Markov chain 1 Middle Aged 1 Ranibizumab 1 Receptors, Vascular Endothelial Growth Factor 1 Recombinant Fusion Proteins 1 Visual Acuity 1 Wet Macular Degeneration 1 Young Adult 1 adolescent 1 adult 1 aflibercept 1 angiogenesis inhibitor 1 best corrected visual acuity 1 brolucizumab cohort analysis 1 controlled study 1 cost benefit analysis 1 cost effectiveness analysis 1 cross-sectional study 1 drug cost 1